Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Operating activities:
Net income (loss)	$ 391	$ (1,367)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Amortization of acquisition-related intangible assets	5,029	4,950
Stock-based compensation plan expense	9,973	11,044
Depreciation and other amortization	7,699	6,092
Deferred income tax expense (benefit)	227	(368)
Provision for allowances on accounts receivable	89	67
Amortization of debt issuance costs	103	103
Amortization of premium (discount) on investments	5	(28)
(Gain) loss on other investments	(48)	0
Loss on disposal of equipment	15	35
(Gain) loss on foreign exchange	(53)	259
Changes in operating assets and liabilities:
Accounts receivable	2,349	11,025
Prepaid expenses and other current assets	(1,971)	(3,268)
Operating lease right-of-use asset, net	303	975
Other assets	(1,164)	(1,077)
Accounts payable	(824)	1,214
Accrued expenses	(1,565)	(571)
Operating lease liabilities	146	(823)
Customer account liabilities	563	1,609
Deferred revenue	(13,484)	(11,969)
Other liabilities	127	210
Net cash provided by operating activities	7,910	18,112
Investing activities:
Acquisition of businesses and assets, net of cash acquired	(9,892)	0
Purchases of other investments	0	(87)
Issuance of note receivable	(1,600)	0
Purchases of available-for-sale securities	(2,929)	(6,274)
Proceeds from sales of available-for-sale securities	2,900	3,700
Capital expenditures, including capitalization of software costs	(8,628)	(11,449)
Net cash used in investing activities	(20,149)	(14,110)
Financing activities:
Repurchase of common stock	0	(10,005)
Repayment of notes payable	0	(182)
Proceeds from exercise of stock options and employee stock purchase plan	2,168	2,174
Net cash provided by (used in) financing activities	2,168	(8,013)
Effect of exchange rate changes on cash	3,294	(1,970)
Decrease in cash, cash equivalents and restricted cash	(6,777)	(5,981)
Cash, cash equivalents and restricted cash at beginning of period	201,136	97,801
Cash, cash equivalents and restricted cash at end of period	194,359	91,820
Cash, cash equivalents and restricted cash at end of period	194,359	91,820
Supplemental disclosures of non-cash investing activities:
Issuance of common stock in connection with acquisition	$ 8,183	$ 0